I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Satlin, Andrew
101
results:
Search for persons
X
Format
Online (101)
Mediatypes
Articles (Online) (72)
Bookchapter (Online) (1)
OpenAccess-fulltext (28)
Sorted by: Relevance
Sorted by: Year
?
1
Adjunctive lumateperone (ITI‐007) in the treatment of bipol..:
Suppes, Trisha
;
Durgam, Suresh
;
Kozauer, Susan G.
...
Bipolar Disorders. 25 (2023) 6 - p. 478-488 , 2023
Link:
https://doi.org/10.1111/..
?
2
Lumateperone (ITI−007) in the Treatment of Bipolar Depressi..:
D'Souza, Ian
;
Durgam, Suresh
;
Satlin, Andrew
...
CNS Spectrums. 26 (2021) 2 - p. 150-150 , 2021
Link:
https://doi.org/10.1017/..
?
3
Safety and tolerability of lumateperone for the treatment o..:
Kane, John M
;
Durgam, Suresh
;
Satlin, Andrew
...
International Clinical Psychopharmacology. 36 (2021) 5 - p. 244-250 , 2021
Link:
https://doi.org/10.1097/..
?
4
Cardiometabolic Safety of Lumateperone (ITI−007): Post Hoc ..:
Edwards, John B.
;
Satlin, Andrew
;
Durgam, Suresh
...
CNS Spectrums. 26 (2021) 2 - p. 152-152 , 2021
Link:
https://doi.org/10.1017/..
?
5
Safety and tolerability of lumateperone 42 mg: An open-labe..:
Correll, Christoph U.
;
Vanover, Kimberly E.
;
Davis, Robert E.
...
Schizophrenia Research. 228 (2021) - p. 198-205 , 2021
Link:
https://doi.org/10.1016/..
?
6
185 The Safety and Tolerability of Lumateperone 42 mg for t..:
Kane, John M
;
Vanover, Kimberly E
;
Durgam, Suresh
...
CNS Spectrums. 25 (2020) 2 - p. 316-317 , 2020
Link:
https://doi.org/10.1017/..
?
7
Cardiac and Hemodynamic Effects of Acute Phosphodiesterase-..:
Gilotra, Nisha A.
;
Devore, Adam
;
Hays, Allison
...
Journal of Cardiac Failure. 26 (2020) 10 - p. S12 , 2020
Link:
https://doi.org/10.1016/..
?
8
186 Results From a 12-Month Open-label Safety Study of Luma..:
Correll, Christoph U.
;
Vanover, Kimberly E
;
Durgam, Suresh
...
CNS Spectrums. 25 (2020) 2 - p. 317-318 , 2020
Link:
https://doi.org/10.1017/..
?
9
M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC..:
Correll, Christoph
;
Mates, Sharon
;
Huo, Jason
...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S214-S214 , 2020
Link:
https://doi.org/10.1093/..
?
10
S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT O..:
Harvey, Philip D
;
Satlin, Andrew
;
Mates, Sharon
...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S123-S123 , 2020
Link:
https://doi.org/10.1093/..
?
11
T205. LUMATEPERONE IN THE TREATMENT OF SCHIZOPHRENIA: EVALU..:
Kane, John M
;
Mates, Sharon
;
Vanover, Kimberly E
...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S310-S310 , 2020
Link:
https://doi.org/10.1093/..
?
12
Evaluation of long-term safety, tolerability, and behaviora..:
Arzimanoglou, Alexis
;
Ferreira, Jose
;
Satlin, Andrew
...
European Journal of Paediatric Neurology. 23 (2019) 1 - p. 126-135 , 2019
Link:
https://doi.org/10.1016/..
?
13
30 Lumateperone (ITI-007) for the Treatment of Schizophreni..:
Vanover, Kimberly
;
Glass, Steven
;
Kozauer, Susan
...
CNS Spectrums. 24 (2019) 1 - p. 190-191 , 2019
Link:
https://doi.org/10.1017/..
?
14
ITI-214, A Novel Phosphodiesterase I Inhibitor for the Trea..:
Davis, Robert
;
Riesenberg, Robert
;
Laskowitz, Daniel
...
Neurology. 92 (2019) 15_supplement - p. , 2019
Link:
https://doi.org/10.1212/..
?
15
S117. FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE II..:
Vanover, Kimberly
;
Satlin, Andrew
;
Durgam, Saresh
...
Schizophrenia Bulletin. 45 (2019) Supplement_2 - p. S351-S351 , 2019
Link:
https://doi.org/10.1093/..
1-15